Open AccessIn the coming year we should abandon interferons and glatiramer acetate as first line therapy for MS: No
Author(s) -
Jan Hillert
Publication year - 2013
Publication title -
multiple sclerosis journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.729
H-Index - 131
eISSN - 1477-0970
pISSN - 1352-4585
DOI - 10.1177/1352458512470312
Subject(s) - glatiramer acetate , multiple sclerosis , medicine , oncology , immunology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom